Vaccine renaissance

Nature Reviews Microbiology

Volumn 5, Issue 7, 2007, Pages 478-481

  Almond, Jeffrey W ^a  

^a SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DIPHTHERIA VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INFLUENZA VACCINE; MALARIA VACCINE; MEASLES VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; ROTAVIRUS VACCINE; SHIGELLA VACCINE; TETANUS TOXOID; VACCINE; VARICELLA ZOSTER VACCINE; WART VIRUS VACCINE; YELLOW FEVER VACCINE;

COST EFFECTIVENESS ANALYSIS; EDITORIAL; INFECTION; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RISK REDUCTION;

ANIMALS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; DRUG DESIGN; HUMANS; PRIVATE SECTOR; PUBLIC SECTOR; RESEARCH; VACCINES;

PRUNUS DULCIS;

EID: 34250322994     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1702     Document Type: Editorial

References (14)

1. Jones, T. Vaccines against human papilloma viruses. Curr. Opin. Investig. Drugs 7, 699-701 (2006).
2. Rappuoli, R. & Covacci, A. Reverse vaccinology and genomics. Science 302, 602 (2003).
3. Pizza, M. et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816-1820 (2000).
4. Kelly, D. F. & Rappuoli, R. Reverse vaccinology and vaccines for serogroup B Neisseria meningitidis. Adv. Exp. Med. Biol. 568 217-223 (2005).
5. Hensel, M. et al. Simultaneous identification of bacterial virulence genes by negative selection. Science 269, 400-403 (1995).
6. Shea, J. E., Santangelo, J. D. & Feldman, R. G. Signature-tagged mutagenesis in the identification of virulence genes in pathogens. Curr. Opin. Microbiol. 3, 451-458 (2000).
7. Meinke, A., Henics, T., Hanner, M., Minh, D. B. & Nagy, E. Antigenome technology: A novel approach for the selection of bacterial vaccine candidate antigens. Vaccine 23, 2035-2041 (2005).
8. Poehling, K. A. et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 295, 1668-1674 (2006).
9. Garland, S. M. et al. An evaluation of non-inferiority in antibody response to human papillomavirus (HPV) 16 in subjects vaccinated with monovalent (HPV 16) and quadrivalent (HPV 6,11,16,18) L1 virus-like particle vaccines. Clin. Vaccine Immunol. 11 Apr 2007 (doi:10.1128/CVI.00478-06v1).
10. Rothman, K. J., Young, X. Y. & Arellano, F. Age dependence of the relation between reassortant rotavirus vaccine (RotaShield) and intussusception. J. Infect. Dis. 193, 898 (2006).
11. Parashar, U. D. & Glass, R. I. Progress toward rotavirus vaccines. Science 312, 851-852 (2006).
12. O'Ryan, M. Rotarix (RIX4414): An oral human rotavirus vaccine. Expert Rev. Vaccines 6, 11-19 (2007).
13. Matson, D. O. The pentavalent rotavirus vaccine, RotaTeq. Sem. Ped. Infect. Dis. 17, 195-199 (2006).
14. Kaslow, D. C. Biological feasibility of developing prophylactic vaccines for viral pathogens. Hum. Vaccin. 3, 1-7 (2007).